Condition

Lenvatinib clinical trials and research

• 7Clinical trials
• 1Country

Newest Lenvatinib clinical trials

All recruiting trials (7)

• Predicting post-surgery treatment for liver cancer using AI and whole-slide images

  Aims to see if an AI model based on postoperative tissue images and imaging data can help decide if patients with hepatocellular carcinoma should receive adjuvant therapy after surgery.

  Recruiting Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang · NCT07417800

• Treatment for ruptured liver cancer using TACE, Lenvatinib, and PD-1 inhibitors

  This study is testing a new treatment that combines a special type of chemotherapy with Lenvatinib and PD-1 inhibitors to see if it can help patients with serious liver cancer that has ruptured.

  Recruiting Sun Yat-sen University · Beijing, None Selected · NCT06740370

• Comparing TACE-Lenvatinib with TACE-Lenvatinib-ablation for recurrent liver cancer

  This study is testing if adding ablation to the combination of TACE and Lenvatinib can help people with recurrent liver cancer feel better compared to just using TACE and Lenvatinib alone.

  Recruiting Sun Yat-sen University · Beijing, None Selected · NCT06609850

• Ablation combined with lenvatinib and PD-1 inhibitor for advanced liver cancer with limited metastases

  This study is testing if combining a targeted treatment with a special type of therapy can help people with advanced liver cancer that has spread a little, to see if it improves their chances of living longer.

  Recruiting Sun Yat-sen University · Beijing, None Selected · NCT06550921

• Combining chemotherapy and targeted therapy for advanced liver cancer

  This study is testing whether combining a specific type of chemotherapy with two targeted therapies can help people with advanced liver cancer feel better and improve their treatment results.

  Recruiting Sun Yat-sen University · Beijing, Beijing Municipality · NCT06333561

• Combining Lenvatinib, Tislelizumab, and TACE for Liver Cancer Treatment

  This study is testing a new combination treatment for liver cancer to see if it can help patients at high risk of their cancer coming back after surgery.

  Recruiting Phase 2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT05920863

• Microwave ablation combined with lenvatinib for recurrent liver cancer

  This study is testing whether combining microwave ablation with the drug lenvatinib can help people with recurrent liver cancer feel better and live longer.

  Recruiting Sun Yat-sen University · Changsha, Hunan · NCT05444478

Related topics

Quick answers

How many Lenvatinib clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →